Effects of Thoracic Erector Spinae Plane Blockade on Acute and Chronic Pain After Video Assisted Thoracoscopic Surgery (VATS)
Unknown statusPhase 4NCT04208542
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a prospective randomized study intended to assess the efficacy of erector spinae plane analgesia on acute and chronic postoperative pain for VATS procedures. It will include 72 patients presenting to Severance hospital for a VATS procedure. Patients will be randomized 1:1 to receive either ESP block and intravenous patient-controlled analgesia (IV PCA) or IV PCA only. Ropivacaine will be used in nerve block, and injected at the end of surgery. The primary outcome will be to compare analgesic efficacy between the two groups as defined by immediate postoperative pain scores on the numeric pain rating scale. Secondary outcomes include total opioid consumption, painDETECT score, and chronic pain scores.
Study details
- Official title
- Effects of Thoracic Erector Spinae Plane Blockade on Acute and Chronic Pain After Video Assisted Thoracoscopic Surgery (VATS)
- Conditions
- Thoracic
- Interventions
- Drug: ESP block
- Sponsor
- Yonsei University
- Start date
- 2019-04-01
- Primary completion
- 2020-12
- Sex
- All
- Age range
- from 20 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Male and Female participants providing written informed consent, 2. ASA grade 1-3, 3. aged over 20 and under 80, 4. primary lung cancer participants scheduled segmentectomy or lobectomy c MLND, 5. undergoing a VATS procedure under General Anaesthesia Exclusion Criteria: 1. Absence of informed written consent, 2. chemotherapy before or after surgery, 3. pre existing infection at block site, 4. severe coagulopathy, 5. pre existing neurological deficit, 6. previous history of opiate abuse, 7. pregnancy, 8. pre existing chronic pain condition,
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04208542